Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gazyva
Pharma
Roche's Gazyva tees up another lupus expansion with phase 3 win
After winning an expansion into lupus-related kidney disease, Gazyva showed its worth in systemic lupus erythematosus, the most common type of lupus.
Zoey Becker
Nov 3, 2025 11:41am
Roche pads case for Gazyva in immune-mediated kidney conditions
Oct 28, 2025 9:55am
Roche's cancer med Gazyva scores FDA nod in lupus nephritis
Oct 20, 2025 10:15am
Roche's Gazyva succeeds in key lupus nephritis trial
Feb 7, 2025 11:14am
Roche's Gazyva chases new kidney disease use with phase 3 win
Sep 26, 2024 11:30am
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
Mar 7, 2024 4:08pm
